Indian stocks: Visit www.stage2stocks.com →

Advanced Biomed Inc.

Stage 3 · Topping · week 3

As of Oct 22, 2026, Advanced Biomed is in Stage 3, the topping phase, now in week 3 (since Oct 6, 2026). It closed at $3.46, 81.8% below its 52-week high and below its 200-day average, which is falling.

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. More about the company

$3.46
-2.81% today
$5.7M · Micro cap
Market Neutral — Building

Pro read

Pro

Our read

Topping: the uptrend is tiring

Setup score

—

Momentum

Steady

Edge

—

Is ADVB early, or has it already run? Pro answers that for every US stock we cover, after every close.

Get Pro · $19 a month

Renews monthly until you cancel. Cancel any time in Plan & billing.

Loading price chart…
Stage Cycle Timeline2025-03-06 → 2026-10-22
S? 41w
S4 19w
S2 9w
2025-03-062026-10-22
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 41w → S4 19w → S1 5w → S4 6w → S1 2w → S2 9w → S3 2w current
Total tracked: 85 weeks across 7 stage runs.

ADVB among Diagnostics & Research40th of 44 by relative strength

All 44 →
Stocks in Diagnostics & Research ranked by relative strength, with stage and one-month change
#StockStageRS1M
1CDNAStage 2 · wk 2499+27.3%
2BDSXStage 2 · wk 1898−18.3%
3ILMNStage 2 · wk 2497+5.5%
4GHStage 2 · wk 2197−7.6%
5NTRAStage 2 · wk 2096+2.7%
6CRLStage 2 · wk 1692+22.5%
7RVTYStage 2 · wk 1890+10.7%
8PSNLStage 2 · wk 1790−3.2%
…40ADVBStage 3 · wk 317−45.3%
vs 52W High
-81.8%
$3.46 lo$18.98 hi
81.8% below 52W high, weakening from peak
The stock is rolling over from its 52-week high. In Stage 3 distribution, new long positions carry high risk.
Stage Maturity
Week 3
1w13w26w
Week 3, early distribution
How long this stock has been in Stage 3 distribution. Longer tops often precede deeper Stage 4 declines.
vs 200 DMA
-42.8%
200 DMA: $6.05 · sloping down
Stock is losing its 200 DMA. Once lost, it confirms Stage 4 risk. This is a major red flag for existing holders.
Rel Volume
0.09x
vs 50-day avg
Volume spikes on down days during Stage 3 signal distribution, with institutions exiting. Stage analysis reads that as a warning against new long positions.
Trend Health
↓
Short-term trend rolling over
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
-45.3%
3M
-81.8%
6M
-46.5%
YTD
-42.7%
1Y
-64.8%
Scan Membership
Not in any current scan.
Recent Stage Timeline
2026-10-22S3
Wk 3 · Vol 0.09x
2026-10-21S3
Wk 3 · Vol 0.20x
2026-10-20S3
Wk 3 · Vol 0.17x
2026-10-19S3
Wk 2 · Vol 3.12x
2026-10-16S3
Wk 2 · Vol 0.22x
2026-10-15S3
Wk 2 · Vol 0.08x
2026-10-14S3
Wk 2 · Vol 0.10x
2026-10-13S3
Wk 2 · Vol 0.03x
2026-10-12S3
Wk 1 · Vol 0.16x
2026-10-09S3
Wk 1 · Vol 0.06x
2026-10-08S3
Wk 1 · Vol 0.15x
2026-10-07S3
Wk 1 · Vol 0.15x
Moving averages & range
50 DMA
$7.20
200 DMA
$6.05
52W High
$18.98
52W Low
$3.46
5D Low
$3.46
Resistance levels (recent highs)
20d High
$6.91
60d High
$10.44
120d High
$18.98
250d High
$18.98
Next resistance
+99.7%
to 20d High
ROE
-79.5%
Profit margin +5231.3%
Dividend Yield
0.00%
P/B 0.5

Advanced Biomed: quick answers

What stage is Advanced Biomed in?

As of Oct 22, 2026, Advanced Biomed (ADVB) is in Stage 3, the topping phase. It entered Stage 3 on Oct 6, 2026 and is in week 3. What the four stages mean

Is Advanced Biomed in an uptrend?

Its uptrend has stalled. Advanced Biomed is in Stage 3, the topping phase that follows an advance. It trades 42.8% below its 200-day average, which is falling.

How far is Advanced Biomed from its 52-week high?

Advanced Biomed closed at $3.46 on Oct 22, 2026, 81.8% below its 52-week high of $18.98. Its 52-week low is $3.46.

How has Advanced Biomed performed over the past year?

As of Oct 22, 2026, Advanced Biomed is down 64.8% over the past year and down 42.7% so far in 2026.

Which sector and industry is Advanced Biomed in?

Advanced Biomed is in the Diagnostics & Research industry, part of the Health Care sector.

About this companyHealth Care· Diagnostics & Research

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies for precision oncology detection, diagnosis, and treatment in Taiwan. It offers A+Pre, a device that prepares blood samples for testing; the AC-1000, a device that separates cancer cells from the rest of the blood; A+SCDrop, a device that isolates individual cells; and A+CellScan, a device that stains and automatically counts cancer cells. The company provides developed dye kits used to identify different types of cancer cells. It also offers FinTruth financial verification agent platform, an enterprise AI financial verification platform designed to compare and verify financial analysis and AI-generated financial content against underlying source documents and financial rules, and to produce source-traceable and auditable results. The company was founded in 2014 and is based in Tsuen Wan, Hong Kong.

Visit company website →

All analytics based on EOD data. Data as of 2026-10-22. Past data patterns are not indicative of future results. This page is a data analytics tool only.